Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07080866 · ClinicalTrials.gov registry record
Brain Health Oneida
A clinical trial of Oneida Nation Members, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 19
- Enrollment target
- 2
- Study locations
NCT07080866: Completed study of Oneida Nation Members, sponsored by University of Wisconsin, Madison.
NCT07080866 is a study of Oneida Nation Members that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 19 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07080866, a study of Oneida Nation Members, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this observational study is to better understand the relationship between stroke risk factors and brain MRI measures in the Native American population. Participants will undergo: * Carotid ultrasound * Magnetic resonance imaging (MRI) * Cognitive testing
Primary Outcome
Cortical thickness is measured using T1w MRI imaging. Normal thickness is 1-4.55mm - average is about 2.5mm, below that range is considered thinning.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Carotid ultrasound
Study Locations (2)
Wisconsin
- University of Wisconsin - Madison - Madison
- Oneida Nation Reservation - Oneida
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2026-02-23 |
What the finished NCT07080866 record still lists
NCT07080866 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 1 condition, with Oneida Nation Members appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT07080866 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07080866 about?
NCT07080866 is a clinical study titled "Brain Health Oneida". The purpose of this observational study is to better understand the relationship between stroke risk factors and brain MRI measures in the Native American population. Participants will undergo: * Carotid ultrasound * Magnetic resonance imaging (MRI) * Cognitive testing
What is the current status of trial NCT07080866?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2025-09-02. Estimated completion is 2026-02-23.
What conditions does trial NCT07080866 study?
This clinical trial studies the following conditions: Oneida Nation Members.
What interventions are being tested in trial NCT07080866?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST), Carotid ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07080866?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07080866 being conducted?
This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oneida Nation Members
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI